INVA FY 2012 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$136M+453.8% YoY

Gross Profit

$128M94.0% margin

Operating Income

-$13M-9.6% margin

Net Income

-$19M-13.7% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

-$128M

Free Cash Flow

-$131M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$369M

Total Liabilities

$214M

Stockholders' Equity

$155M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$136M	$25M	+453.8%
Gross Profit	$128M	$25M	+420.6%
Operating Income	-$13M	-$110M	+88.2%
Net Income	-$19M	-$115M	+83.9%